⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2025

Figure S2 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

Tongtong Wu Zhicong Yang Sufan Tang Hongmei Yuan Yang Liu Haiyang Li Nan Liu Zhanwen Huang Yue Chen Zhijun Zhou

View at Publisher

Ask AI

Bookmark

Share

Key Points

Main finding shows that DOTA-ALB-01 effectively targets fibroblasts via its albumin-binding sites.
Key evidence includes detailed ESI-MS spectrum and HPLC analysis supporting ligand efficacy.
Approach employed ESI-MS and HPLC to analyze the binding characteristics of DOTA-ALB-01.
Significance lies in advancing targeted delivery systems for therapeutic applications involving fibroblasts.

Implication

Figure presents ESI-MS and HPLC data on DOTA-ALB-01, highlighting its interaction with fibroblasts and albumin-binding properties.

Abstract

Figure S2. ESI-MS spectrum and HPLC analysis of DOTA-ALB-01. See main text for corresponding analytical conditions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d02b3 https://doi.org/10.1158/1535-7163.29759953

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
2Figure S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
3Figure S1 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
4Figure S7 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
5Figure S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025

Figure S8 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
Figure S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
Figure S11 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025